Reg. no. 5594305921 · Specialist medical practice activities, not at hospitals · NACKA
EndoGyn Sverige AB is registered with the legal form Limited company, is based in NACKA and is active in Specialist medical practice activities, not at hospitals. Revenue for 2025 was 22.8 MSEK.
Fiscal year ending 2025-12-31 · Amounts in SEK
Net revenue
22.8 MSEK
▲ +184%Operating result
-5 MSEK
▼ −22%Net result
-5.5 MSEK
▼ −28%Employees (annual report)
26
▲ +44%Total assets
14.7 MSEK
Equity
6.4 MSEK
Equity ratio
43.9 %
Profit margin
−23.9 %
MSEK
EndoGyn Sverige AB increased net sales by 184.3 % to 22.8 MSEK in 2025. The company’s operating margin went from -51 % to -22 % in 2025. In 2025, net sales corresponded to roughly 878 kSEK per employee (26 employees).
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
EndoGyn Sverige AB's reg. no. is 5594305921.
EndoGyn Sverige AB reported revenue of 22.8 MSEK for the fiscal year 2025.
No — EndoGyn Sverige AB reported a net result of -5.5 MSEK for 2025.
EndoGyn Sverige AB had 26 employees as of the most recently reported period (2025).
EndoGyn Sverige AB is registered under Specialist medical practice activities, not at hospitals.
EndoGyn Sverige AB is based in NACKA.